2025 Genomic Cancer Panel And Profiling Industry Trends Report: Long-Term Outlook Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Genomic Cancer Panel And Profiling Market Size By 2025?
The market size for genomic cancer panel and profiling has seen robust growth in the past few years. It's projected to increase from $9.47 billion in 2024 to $10.28 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.6%. Factors contributing to this growth during the previous years include a heightened global incidence of cancer, increased employment in clinical trials, developments in the diagnostic infrastructure, amplified understanding about genetic testing, and enhanced government and research funding.

How Big Is the Genomic Cancer Panel And Profiling Market Size Expected to Grow by 2029?
The market size of genomic cancer panel and profiling is projected to experience robust growth in the coming years, ultimately reaching a valuation of $14.27 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. This predicted growth during the forecast period can be ascribed to factors such as rising applications of liquid biopsy, heightened usage in early detection, growth of personalized therapies, and increase in approvals for companion diagnostics. Some of the notable trends anticipated during the forecast period include the incorporation of AI and machine learning for interpreting genomic data, the rise of multi-omics approaches, moving genomic data storage and analysis to the cloud, integration with electronic health records, and the expansion of next-generation sequencing (NGS) platforms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genomic-cancer-panel-and-profiling-global-market-report

Which Key Market Drivers Powering Genomic Cancer Panel And Profiling Market Expansion and Growth?
The growing prevalence of cancer is anticipated to boost the expansion of the genomic cancer panel and profiling market in the future. Cancer defines a condition where abnormal cells grow uncontrollably and spread throughout the body. The rising rate of cancer can be linked to factors such as an aging populace that increases the chances of cancer as individuals age. Genomic cancer panels and profiling are utilized in cancer to uncover genetic alterations and biomarkers, facilitating customized treatment approaches and enhancing early detection and tracking of the illness. For example, as stated by the American Cancer Society, a nonprofit organization based in the U.S., about 20 million new cancer cases were document globally in 2022, culminating in 9.7 million fatalities; mainly due to population increase, the global cancer burden is expected to escalate to 35 million cases by 2050. Consequently, the increasing rate of cancer will catalyze the growth of the genomic cancer panel and profiling market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24225&type=smp

What Trends Will Shape the Genomic Cancer Panel And Profiling Market Through 2029 and Beyond?
Leading entities in the genomic cancer panel and profiling market are orienting their focus towards technological advancements such as next-generation sequencers. They aim to bolster the accuracy, speed, and thoroughness of cancer diagnostics and facilitate more personalized treatment options. Advanced DNA sequencing technologies, like the next-generation sequencers, provide quick, high-throughput analysis of genetic substances to pinpoint mutations, variations, and other genetic attributes. An example of this was in April 2025, when QIAGEN N.V., a biotech company based in the Netherlands, initiated QIAseq panels that are designed for next-generation sequencers, which facilitate comprehensive genomic profiling through the analysis of more than 700 genes. These panels are targeted for both academic and clinical purposes, with the goal of refining cancer diagnostics and treatment approaches.

What Are the Emerging Segments in the Genomic Cancer Panel And Profiling Market?
The genomic cancer panel and profiling market covered in this report is segmented -

1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies
3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel
4) By Application: Clinical, Research
5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users

Subsegments:
1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues
2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24225&type=smp

Who Are the Global Leaders in the Genomic Cancer Panel And Profiling Market?
Major companies operating in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc.

Which are the Top Profitable Regional Markets for the Genomic Cancer Panel And Profiling Industry?
North America was the largest region in the genomic cancer panel and profiling market in 2024. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24225

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.